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Figure 4. NAT activity of recombinant hNaa10p WT or p.Ser37Pro 
towards synthetic N-terminal peptides. A) and B) Purified MBP-hNaa10p 
WT or p.Ser37Pro were mixed with the indicated oligopeptide substrates (200 
µM for SESSS and 250 µM for DDDIA) and saturated levels of acetyl-CoA 
(400 µM). Aliquots were collected at indicated time points and the acetylation 
reactions were quantified using reverse phase HPLC peptide separation. 
Error bars indicate the standard deviation based on three independent 
experiments. The five first amino acids in the peptides are indicated, for 
further details see materials and methods. Time dependent acetylation 
reactions were performed to determine initial velocity conditions when 
comparing the WT and Ser37Pro NAT-activities towards different 
oligopeptides. C) Purified MBP-hNaa10p WT or p.Ser37Pro were mixed with 
the indicated oligopeptide substrates (200 µM for SESSS and AVFAD, and 
250 µM for DDDIA and EEEIA) and saturated levels of acetyl-CoA (400 µM) 
and incubated for 15 minutes (DDDIA and EEEIA) or 20 minutes (SESSS and 
AVFAD), at 37°C in acetylation buffer. The acetylation activity was determined 
as above. Error bars indicate the standard deviation based on three 
independent experiments. Black bars indicate the acetylation capacity of the 
MBP-hNaa10p wild type (WT), while white bars indicate the acetylation 
capacity of the MBP-hNaa10p mutant p.Ser37Pro. The five first amino acids 
in the peptides are indicated. 
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Abstract! Methods:  WGS was  performed on  ten  members  of  this  family 
using  the  Il-lumina  HiSeq2000  platform,  with  four  (the  two 
affected  boys  and  their  parents)  being  additionally  sequenced 
using the CG WGS platform. CG data analysis was performed by 
CG,  using  their  version  2.0  pipeline.  Multiple  variant  calling 
pipelines were used to detect SNVs, INDELs, STRs and CNVs.  
Disease variant  prioritization was performed using ANNOVAR, 
Golden Helix SVS v8.1.4 and GEMINI v0.9.1, and VAAST v2.0.!
Results: CG WGS covered >85% of the genome and >90% of the 
exome, both with 20 or more reads. Illumina WGS covered >90% 
of the genome with 30 reads or more and with >80% of the bases 
having a quality score of >30. On average, we find a 2.4 to 14.0 
mean fold difference in the number of variants detected as being 
relevant for various disease models when using different sets of 
sequencing data  and analysis  pipelines.  We found a  number  of 
putative genetic variants and archive them here.!
Background:  We  describe  a  comprehensive  whole  genome 
sequencing  (WGS)  study  using  the  Illumina  and  Complete 
Genomics (CG) sequencing platforms for one family containing 
two  affected  male  brothers,  aged  10  and  12,  with  severe 
intellectual  disability  and  very  distinctive  facial  features.  High 
accuracy and sensitivity is of particular importance in the context 
of  detecting  or  discovering  the  genetic  influencers  of  human 
diseases.!
Fig. 1  (A) Pedigree structure of all individuals in the family that 
were sequenced during the course of this study. Individuals with a 
star next to their number indicates that their whole genomes were 
sequenced  with  both  the  Complete  Genomics  sequencing  and 
analysis pipeline as well as with Illumina sequencing. !
•  Human  sequence  variation  ranges  in  manifestation  from 
differences that can be detected at the single nucleotide level, to 
whole chromosome differences (Fig 2).!
•  Conclusions:  Analyzing  multi-generational  pedigrees  using 
multiple orthogonal bioinformatics pipelines using two sequencing 
platforms can reliably reveal human sequence variants that may be 
important in rare disease. We have found a number of sequence 
variants that may play a role in the rare disease described here and 
highlight a variant in TAF1. Our findings are consistent with the 
literature  on  the  importance  of  the  TF11D  complex  in 
developmental delay and ID.!
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Fig. 2  A conceptual map of human sequence variation, and a list 
of the bioinformatics programs we used during the course of our 
study.!
•  The two affected male brothers have severe intellectual disability, 
autism-like behavior, attention deficit issues, and very distinctive 
facial features (Fig. 1C), including broad, upturned nose, sagging 
cheeks,  downward  sloping  palpebral  fissures,  relative 
hypertelorism, high-arched palate, and prominent ears. !
•  The mother of the two affected (Fig. 1A, II-2) was shown to have 
99:1 x-chromosome inactivation (Fig. 1B).!
•  14 unique INDELS and SNVs were discovered using two different 
prioritization (Fig. 3A).   !
•  The TAF1 variant arose in this family as a de-novo variant on the 
X-chromosome of the mother (Fig. 1A, II-2) of the two affected 
children (as it  is  not found in any of the other members of the 
family) and was then transmitted to both of them.  The mother also 
is the only female in the family to exhibit extreme X-chromosome 
skewing.  !
•  The  transcription  factor  initiation  complex  TF11D has  recently 
been  implicated  in  playing  a  role  in  intellectual  disability  and 
developmental  delay,  and  TAF1  represents  the  largest  known 
subunit of this multi-protein complex, and this variant falls within 
a conserved region of the protein (Fig 3B).!
Fig. 3!
•  We  sought  to  identify  variants  following  de-novo,  autosomal 
recessive  and  x-linked  models  of  transmission  that  may  be 
contributing, together or alone, to the disease phenotype.  We used 
several  methods  to  prioritize  and  identify  possible  disease-
contributory germ-line variants, in-cluding VAAST, Golden Helix 
SVS  v8.1.4,  ANNOVAR  (2013Aug23  version),  and  GEMINI 
v0.9.1.!
Presentation of the phenotype 
Bioinformatics analysis 
Results 
•  We found  a  2.4  to  14.0  mean  fold  difference  in  the  number  of 
variants detected as being relevant for various disease models when 
using different sets of sequencing data. !
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INDELs, especially those disrupting protein-coding regions of the 
genome, have been strongly associated with human diseases. However, 
there are still many errors with INDEL variant calling, driven by 
library preparation, sequencing biases, and algorithm artifacts. We 
characterized whole genome sequencing (WGS), whole exome 
sequencing (WES), and PCR-free sequencing data from the same 
samples to investigate the sources of INDEL errors. We also developed 
a classification scheme based on the coverage and composition to rank 
high and low quality INDEL calls. We performed a validation 
experiment on 600 loci, and find high-quality INDELs to have a 
substantially lower error rate than low quality INDELs (7% vs. 51%). !
Simulation  and  experimental  data  show  that  assembly  based  callers  are 
significantly more sensitive and robust for detecting large INDELs (>5bp) than 
alignment  based  callers,  consistent  with  published  data.  The  concordance  of 
INDEL detection between WGS and WES is low (52%), and WGS data uniquely 
identifies  10.8-fold  more  high-quality  INDELs.  The  validation  rate  for  WGS-
specific INDELs is also much higher than that for WES-specific INDELs (84% 
vs. 57%), and WES misses many large INDELs. In addition, the concordance for 
INDEL detection between standard WGS and PCR-free sequencing is 71%, and 
standard  WGS  data  uniquely  identifies  6.3-fold  more  low-quality  INDELs. 
Furthermore, accurate detection with Scalpel of heterozygous INDELs requires 
1.2-fold higher coverage than that for homozygous INDELs. !
Lastly, homopolymer A/T INDELs are a major source of low-quality 
INDEL calls, and they are highly enriched in the WES data. Overall, we 
show that accuracy of INDEL detection with WGS is much greater than 
WES even in the targeted region. We calculated that 60X WGS depth of 
coverage from the HiSeq platform is needed to recover 95% of INDELs 
detected by Scalpel. While this is higher than current sequencing 
practice, the deeper coverage may save total project costs because of the 
greater accuracy and sensitivity. Finally, we investigate sources of 
INDEL errors (e.g. capture deficiency, PCR amplification, 
homopolymers) with various data that will serve as a guideline to 
effectively reduce INDEL errors in genome sequencing.!
Reducing INDEL calling errors in whole genome and exome sequencing data 
Table 2. Validation rates of WGS-WES intersection INDELs, WGS-specfic, and WES-specific INDELs. We also 
calculated the validation rates of large INDELs (>5 bp) in each category. The validation rate, positive predictive value 
(PPV), is computed by the following: PPV=#TP/(#TP+#FP), where #TP is the number of true-positive calls and #FP is 
the number of false-positive calls. !
INDELs! Valid! PPV! INDELs (>5bp)! Valid (>5bp)! PPV (>5bp)!
WGS-WES intersection! 160! 152! 95.0%! 18! 18! 100%!
WGS-specific! 145! 122! 84.1%! 33! 25! 75.8%!
WES-specific! 161! 91! 56.5%! 1! 1! 100%!
All !
INDELs!
Large INDELs 
(>5bps)!
Fraction of large 
INDELs (>5bp)!
WGS-WES intersection! 2009! 176! 8.8%!
WGS-specific! 494! 104! 21.1%!
WES-specific! 674! 10! 1.5%!
Table 3. Number and fraction of large INDELs in the following INDEL categories: 1) WGS-WES intersection INDELs, 
2) WGS-specific, and WES-specific.  
Figure 7. Concordance of INDEL detection between PCR-free and standard WGS data on NA12878.  Figure 1. Concordance of INDELs over eight samples between WGS (blue) and WES (green) data. !
Figure 8. Percentage of high quality, moderate quality and low quality INDELs in two datasets.!Figure 2. Percentage of high quality, moderate quality and low quality INDELs in three call set. !
Figure 5. Coverage distributions of the exonic targeted regions in (A) the WGS data, (B) the WES data. !
Figure 6. Coverage distributions of the WGS-specific INDELs regions in (A) the WGS data, (B) the WES data. !Figure 3. Percentage of poly-A, poly-C, poly-G, poly-T, other-STR, and non-STR in three call set. ! Figure 9. Percentage of poly-A, poly-C, poly-G, poly-T, other-STR, and non-STR in three call sets.!
Figure 10. Sensitivity performance of INDEL detection with eight WGS datasets at different mean 
coverages on Illumina HiSeq2000 platform. !
Figure 4. Performance comparison between the Scalpel and GATK-UnifiedGenotyper in terms of 
sensitivity (A) and false discovery rate (B) at different coverage (simulation data). !
!Genome Wide Variant Analysis of families with Autism Spectrum 
Disorder (ASD) using an Integrative Bioinformatics Pipeline !
!
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Introduction. Autism spectrum disorders (ASD) are a group of 
developmental  disabilities  that  affect  social  interaction, 
communication  and  are  characterized  by  repetitive  behaviors. 
There is now a large body of evidence that suggests a complex 
role  of  genetics  in  ASD,  in  which  many  different  loci  are 
involved.  Although many current  population scale  studies  have 
been  demonstrably  useful,  these  studies  generally  focus  on 
analyzing a limited part  of  the genome or use a limited set  of 
bioinformatics tools. These limitations make it difficult to see the 
complete and panoramic picture of each ASD case.  To address 
this  problem,  here  we  describe  an  integrative  bioinformatics 
pipeline used to get a more complete and reliable set of candidate 
ASD-variants for validation and further functional analysis. #
Results.  The  resulting  set  of  candidate  variants  include  three  small 
heterozygous CNVs (~22, ~36 and ~50 Kb). All of the CNVs were only 
found  by  ERDS,  and  despite  the  fact  that  the  K21  pedigree  had 
microarray data, PennCNV did not detect any CNV in those regions. A 
heterozygous de novo  nonsense mutation in MYBBP1A  was found in 
one of the quads (K21) located within exon 1, and a second de novo 
variant was also among the final results from another quad (SSC_2), 
this time a missense mutation in LAMB3, which also has not yet been 
observed in any other ASD proband. #
#
Having  established  a  more  comprehensive  WGS  pipeline,  we  are 
moving  to  implement  our  framework  for  the  analysis  and  study  of 
families from Utah and from the SSC . #
 #
Figure  1.  Pedigree  structure  of  a  Simplex  Autism 
Family.  For  a  family  to  be  classified  as  a  Simplex 
Autism Family, it has to be composed of one affected 
child  and  at  least  one  unaffected  sibling,  and  both 
parents  do  not  have  obvious  autism.  Probands  and 
siblings can be either males or females. For this study, 
two of the families have male probands and unaffected 
male  siblings,  whereas  the  other  family  has  a  male 
proband and a female unaffected sibling. #
Figure 2. Variant calling pipeline.  After aligning the genomes with BWA-MEM 0.7.5a-r405,  the 
resulting alignments were converted to binary format, then sorted and indexed using SAMtools version 
0.1.19-44428cd.  Duplicated reads were marked and read groups were assigned to  each lane using 
Picard tools v1.84. The GATK Indel realigner v3.0-0 was used to correct initial mapping artifacts due 
to reads aligning to the edges of INDELs, which often map with mismatching bases that may look like 
evidence for SNPs, while they are not. The GATK Base Quality Score Recalibrator was also used to 
correct known systematic errors of sequencing technologies. Finally all lanes were merged by sample 
with Picard tools to generate a ready-to-use alignment. Various algorithms were used to call SNPs and 
Indels, all resulting variants were filtered and prioritized with different methods. #
Methods. We studied three simplex Autism Families, two of which belong to 
the Simon’s Simplex Collection (SSC), and all probands and families were 
clinically evaluated and extensively phenotyped. The third family, recruited 
at  the  Utah  Foundation  for  Biomedical  Research,  had  extensive  clinical 
evaluations performed, along with fragile X and Chromosomal Microarray 
Analysis  (CMA)  on  the  proband  and  mother,  with  no  obvious  disease-
contributory mutations found. All family members were genotyped using an 
Illumina  Omni2.5  Array  and/or  WGS  was  performed  using  the  Illumina 
HiSeq 2000 to ~40-75X coverage. WGS reads were aligned to the GRCh37/
hg19  human  reference  genome  using  BWA-MEM  software,  with  variant 
calling  for  SNVs  and  INDELs  using  the  GATK  HaplotypeCaller  and 
FreeBayes.  To  better  support  de  novo  calls,  we  used  Scalpel  for  INDEL 
detection and the Multinomial Analyzer. The ERDS software was used to call 
CNVs from WGS data. Microarray data were used to call CNVs with the 
software package PennCNV using the joint-calling algorithm. #
 #
Figure 4. Copy Number Variant calling pipeline. Using the same ready to use alignment described in 
Figure 2 plus the union of variants called by Freebayes and GATK, the Estimation by Read Depth with 
Single Nucleotide Variants (ERDS) software was used to call CNVs. PennCNV was used in the samples 
where Microarray data was available and both calls sets were compared. #
Figure 3. Algorithm concordance. GATK and Freebayes were compared as they are algorithms that 
call  both  SNVs  and  INDELs  with  a  comparable  number  of  calls.  The  intersection  grows  when 
comparing filtered SNVs and Indels. The Multinomial Analyzer and Scalpel were only used to call de 
novo SNPs and Indels respectively. #
Figure 5c.  Genome Browser  Screen cut  for  the  Read Depths  in  the ~ 22 Kb intergenic  CNV on 
16p12.3 (Pedigree K21).#
Figure 5c. Genome Browser Screen cut for the Read Depths in the ~ 50 Kb intergenic CNV on 4p16.3 
(Pedigree SSC_2).#
Figure 5c. Genome Browser Screen cut for the Read Depths in the ~ 36 Kb intergenic CNV on 3q22.1 
(Pedigree K21).#
Figure 3a. Raw SNV! Figure 3b. Filtered SNV!
Figure 3c. Raw Indels!           Figure 3d. Filtered SNV!
•  Mark	  Yandell	  will	  visit	  CSHL	  from	  Utah	  and	  
give	  a	  seminar	  about	  the	  Utah	  Genome	  
Project	  on	  Wednesday,	  December	  10th	  at	  4	  PM	  
in	  Hawkins.	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  Age	  54	  
	  	  	  	  	  	  	  	  	  	  Age	  25	  	  	  	  	  	  	  	  	  	  	  Age	  24	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Age	  19	  
	   	   	   	   	   	   	  	  	  	  	  	  	  prodromal,	  at	  risk	  
Collected	  ~100	  DNA	  samples	  from	  the	  extended	  family,	  due	  to	  very	  large	  excess	  
of	  major	  depression,	  	  bipolar,	  Toure^e	  and	  OCD.	  
Expanding	  the	  Pedigree	  –K8101	  
Case	  Presenta)on	  
! Male,	  age	  55	  currently.	  
! PsychoKc	  break	  at	  age	  20	  with	  bipolar	  features.	  
! EvoluKon	  into	  schizoaﬀecKve	  disorder	  over	  next	  25	  years.	  
! Also	  with	  severe	  obsessive	  compulsive	  disorder	  and	  severe	  Toure^e	  Syndrome	  
! At	  least	  two	  very	  severe	  suicide	  a^empts	  at	  age	  22,	  including	  throwing	  self	  
under	  a	  truck	  one	  Kme	  and	  then	  driving	  head-­‐on	  into	  another	  car	  (with	  death	  
of	  two	  passengers	  in	  other	  car,	  found	  not	  guilty	  by	  reason	  of	  insanity).	  
! Extensive	  medicaKon	  trials	  over	  many	  years,	  along	  with	  anterior	  capsulotomy	  
with	  very	  li^le	  eﬀect	  for	  the	  OCD.	  
	  
! Current	  meds:	  
	  	  	  	  	  	  	  	  	  Klonopin	  	  
	  NicoKnamide	  
	  Lunesta 	   	   	   	  	  
	  AKvan	  
	  
	  	  
	  	  
	  Lithium	  
	  Seroquel	  
	  Lamictal	  
	  Luvox	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  sluchainost’	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Recent advances in sequencing technology are making possible the application of large-scale genomic anal-
yses to individualized care, both in wellness and disease. However, a number of obstacles remain before ge-
nomic sequencing can become a routine part of clinical practice. One of the more signiﬁcant and
underappreciated is the lack of consensus regarding the proper environment and regulatory structure
under which clinical genome sequencing and interpretation should be performed. The continued reliance
on pure research vs. pure clinical models leads to problems for both research participants and patients in
an era in which the lines between research and clinical practice are becoming increasingly blurred. Here,
we discuss some of the ethical, regulatory and practical considerations that are emerging in the ﬁeld of geno-
mic medicine. We also propose that many of the cost and safety issues we are facing can be mitigated through
expanded reliance on existing clinical regulatory frameworks and the implementation of distributive
work-sharing strategies designed to leverage the strengths of our genomics centers and clinical interpretive
teams.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
We are entering a fascinating and uncertain period of medical his-
tory, as today's DNA sequencing technology has the potential to help
each of us direct our care and predict our future based on knowledge
of our own individual inherited and acquired genetics. However,
from a global and local economic perspective, these are lean years,
and this adds a signiﬁcant degree of uncertainty to the immediate fu-
ture of this enterprise. It is therefore incumbent upon us to show that
the personalized medical application of large-scale genomic analysis
will not just be a luxury or a burdensome cost center, but that it
truly has the potential to save both lives and health care expenses
via data-driven management, early disease detection/screening and
more efﬁcacious pharmaceutical delivery. To this end, we need to de-
termine how to move forward towards expanded clinical use of this
technology in a manner both rapid and economical, while ensuring
the integrity of the process and the safety and well-being of patients
and research participants. This will require careful thought and con-
sideration regarding the proper environment and regulatory structure
surrounding genomics, as well as the development of consensus re-
gardingwhat exactly constitutes a genetic test in the age of large-scale
genomics and informatics.
2. Paving the way for the broad implementation of clinical
genomic medicine
A report published in 2011 by the National Research Council for
the National Academy of Sciences elegantly described the major divi-
sions between the clinical and research worlds, including in regards
to large-scale genomic analyses, such as whole genome (WGS) se-
quencing. The report went on to offer suggestions for how to help
merge these two worlds, including articulating the need for a “Knowl-
edge Network” and “New Taxonomy”, with the recommendation that
pilot studies along such lines should be conducted (Anon., 2011).
However, the report did not address a critical issue related to genetic
testing, namely the rules that should govern genomic research and
clinical care as we move into the coming era of individualized medi-
cine. The United States federal government mandates that any labora-
tory performing tests on human specimens “for the purpose of
providing information for the diagnosis, prevention, or treatment of
any disease”must satisfy the conditions set forth in the Clinical Labo-
ratory Improvement Amendments (CLIA) of 1988 (Group®, 2012).
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Low concordance of multiple variant-calling
pipelines: practical implications for exome and
genome sequencing
Jason O’Rawe1,2, Tao Jiang3, Guangqing Sun3, Yiyang Wu1,2, Wei Wang4, Jingchu Hu3, Paul Bodily5, Lifeng Tian6,
Hakon Hakonarson6, W Evan Johnson7, Zhi Wei4, Kai Wang8,9* and Gholson J Lyon1,2,9*
Abstract
Background: To facilitate the clinical implementation of genomic medicine by next-generation sequencing, it will
be critically important to obtain accurate and consistent variant calls on personal genomes. Multiple software tools
for variant calling are available, but it is unclear how comparable these tools are or what their relative merits in
real-world scenarios might be.
Methods: We sequenced 15 exomes from four families using commercial kits (Illumina HiSeq 2000 platform and
Agilent SureSelect version 2 capture kit), with approximately 120X mean coverage. We analyzed the raw data using
near-default parameters with five different alignment and variant-calling pipelines (SOAP, BWA-GATK, BWA-SNVer,
GNUMAP, and BWA-SAMtools). We additionally sequenced a single whole genome using the sequencing and
analysis pipeline from Complete Genomics (CG), with 95% of the exome region being covered by 20 or more
reads per base. Finally, we validated 919 single-nucleotide variations (SNVs) and 841 insertions and deletions
(indels), including similar fractions of GATK-only, SOAP-only, and shared calls, on the MiSeq platform by amplicon
sequencing with approximately 5000X mean coverage.
Results: SNV concordance between five Illumina pipelines across all 15 exomes was 57.4%, while 0.5 to 5.1% of
variants were called as unique to each pipeline. Indel concordance was only 26.8% between three indel-calling
pipelines, even after left-normalizing and intervalizing genomic coordinates by 20 base pairs. There were 11% of
CG variants falling within targeted regions in exome sequencing that were not called by any of the Illumina-based
exome analysis pipelines. Based on targeted amplicon sequencing on the MiSeq platform, 97.1%, 60.2%, and 99.1%
of the GATK-only, SOAP-only and shared SNVs could be validated, but only 54.0%, 44.6%, and 78.1% of the GATK-
only, SOAP-only and shared indels could be validated. Additionally, our analysis of two families (one with four
individuals and the other with seven), demonstrated additional accuracy gained in variant discovery by having
access to genetic data from a multi-generational family.
Conclusions: Our results suggest that more caution should be exercised in genomic medicine settings when
analyzing individual genomes, including interpreting positive and negative findings with scrutiny, especially for
indels. We advocate for renewed collection and sequencing of multi-generational families to increase the overall
accuracy of whole genomes.
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the SNV calls made by the GATK UnifiedGenotyper ver-
sion 1.5, showing an overall concordance of 91.0% (27,150
of 29,912) and 87.0% (26,751 of 30779) respectively. How-
ever, for indel calls, the picture was quite different, with
the GATK UnifiedGenotyper version 2.3-9 and GATK
HaplotypeCaller version 2.3-9 modules showing an overall
concordance with the GATK UnifiedGenotyper version
1.5 calls of 54.7% (1,688 of 3,085) and 54.6% (1,858 of
3,404) respectively (see Additional file 1, Figure S10).
Discussion
Significant advances have been made in detecting genomic
variation in ‘next-generation’ sequencing data, despite con-
siderable sources of uncertainty [13]. However, we have
f und that there still exists significant discrepancy between
the overall variant sets called by five different variant-call-
i g pipelines applied to the same raw seque cing d ta
using near-default parameters, along with differences
noted between two next-generation sequencing (NGS)
platforms. There are, of course, relatively large regions of
overlap between all pipelines even when highly specialized
parameterizations are not used. This suggests that there
exists a ‘region’ of variants that can be called robustly by
many different pipelines regardless of meticulous parame-
terization. The field has naturally focused on this robust
set of calls, but we wish to highlight here the considerable
degree of discordance as well as the high false-negative
rates.
A discussion ab ut variant quality and the case for
multiple methods for sequence analysis in personal
genomes
For the five variant-calling pipelines included in our study,
a large number of calls (both SNV and indel) are shared
among them in each exome, 21,146 on average for SNVs.
Although all five pipelines converge on a relatively large
number of SNVs, this still represents less than 60% of the
total SNV call set determined by all fi e pipelines, and
hence there still exists a considerable degree of variation
between pipelines used, with near-default parameterization
on the same raw sequencing data. This disagreement is
likely to be the result of many factors including alignment
Figure 4 Indel concordance for a single exome, k8101-49685, between two sequencing pipelines: Illumina and Complete Genomics
(CG). Illumina indels consist of a union of all indels called by each of the three indel-calling pipelines GATK, SOAPindel, and SAMtools. CG indels
consisted of a subset of indels called by CG that fell within the Agilent SureSelect version 2 exons. Both Illumina and CG indels were left
normalized an intervalized to a range of 20 genomic coordinates (10 coordinat s on each side of the normalized position). To determine
whether or not indels were matching, the genomic coordinates as well as the base length and composition of each indel were considered.
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Reducing INDEL calling errors in whole genome
and exome sequencing data
Han Fang1,2,3, Yiyang Wu1,2, Giuseppe Narzisi3,4, Jason A O’Rawe1,2, Laura T Jimenez Barrón1,5, Julie Rosenbaum3,
Michael Ronemus3, Ivan Iossifov3, Michael C Schatz3* and Gholson J Lyon1,2*
Abstract
Background: INDELs, especially those disrupting protein-coding regions of the genome, have been strongly associated
with human diseases. However, there are still many errors with INDEL variant calling, driven by library preparation,
sequencing biases, and algorithm artifacts.
Methods: We characterized whole genome sequencing (WGS), whole exome sequencing (WES), and PCR-free sequencing
data from the same samples to investigate the sources of INDEL errors. We also developed a classification scheme
based on the coverage and composition to rank high and low quality INDEL calls. We performed a large-scale
validation experiment on 600 loci, and find high-quality INDELs to have a substantially lower error rate than low-quality
INDELs (7% vs. 51%).
Results: Simulation and experimental data show that assembly based callers are significantly more sensitive and robust
for detecting large INDELs (>5 bp) than alignment based callers, consistent with published data. The concordance of
INDEL detection between WGS and WES is low (53%), and WGS data uniquely identifies 10.8-fold more high-quality
INDELs. The validation rate for WGS-specific INDELs is also much higher than that for WES-specific INDELs (84% vs. 57%),
and WES misses many large INDELs. In addition, the concordance for INDEL detection between standard WGS and
PCR-free sequencing is 71%, and standard WGS data uniquely identifies 6.3-fold more low-quality INDELs. Furthermore,
accurate detection with Scalpel of heterozygous INDELs requires 1.2-fold higher coverage than that for homozygous
INDELs. Lastly, homopolymer A/T INDELs are a major source of low-quality INDEL calls, and they are highly enriched in
the WES data.
Conclusions: Overall, we show that accuracy of INDEL detection with WGS is much greater than WES even in the
targeted region. We calculated that 60X WGS depth of coverage from the HiSeq platform is needed to recover 95% of
INDELs detected by Scalpel. While this is higher than current sequencing practice, the deeper coverage may save total
project costs because of the greater accuracy and sensitivity. Finally, we investigate sources of INDEL errors (for example,
capture deficiency, PCR amplification, homopolymers) with various data that will serve as a guideline to effectively reduce
INDEL errors in genome sequencing.
Background
With the increasing use of next-generation sequencing
(NGS), there is growing interest from researchers, physi-
cians, patients, and consumers to better understand the
underlying genetic contributions to various conditions. For
rare diseases and cancer studies, there has been increasing
success with exome/genome sequencing in identifying mu-
tations that have a large effect size for particular pheno-
types [1-3]. Some groups have been trying to implement
genomic and/or electronic health record approaches to
interpret disease status and inform preventive medicine
[4-8]. However, we are still facing practical challenges for
both analytic validity and clinical utility of genomic medi-
cine [9-13]. In addition, the genetic architecture behind
most human disease remains unresolved [14-19]. Some
have argued that we should bring higher standards to hu-
man genetics research in order to return results and/or re-
duce false-positive reports of ‘causality’ without rigorous
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3Simons Center for Quantitative Biology, Cold Spring Harbor Laboratory, One
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1Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory,
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Two major paradigms are currently used for detecting indels. 
The first and most common approach is to map all of the input 
reads to the reference genome using a read mapper (such as 
Burrows-Wheeler Alignment tool (BWA), Bowtie or Novoalign), 
although the available algorithms are not as effective for mapping 
across indels of more than a few base pairs. Advanced approaches 
use paired-end information to perform local realignments to 
detect longer mutations (tools include GATK UnifiedGenotyper1 
and Dindel9), although, in practice, their sensitivity is greatly 
reduced for longer (q30 bp) variants. Split-read methods (such 
as Pindel10 and Splitread11) can theoretically find deletions of any 
size, but they have limited power to detect insertions owing to the 
short read length of current sequencing technologies. The second 
paradigm consists of performing de novo whole-genome assembly 
of the reads and detecting variations between the assembled con-
tigs and the reference genome12,13. Although it has the potential 
to detect larger mutations, in practice this paradigm is less sensi-
tive because detecting indels requires a fine-grained and localized 
analysis to correctly report homozygous and heterozygous muta-
tions. Recently, three approaches hav  been developed that use 
de novo assembly for variation discovery: GATK HaplotypeCaller, 
SOAPindel14 and Cortex15. Another recent approach, TIGRA16, 
also uses localized assembly, but it has been tailored for break-
point detection without reporting the indel sequence.
We present a DNA sequence microassembly pipeline, Scalpel, 
for detecting indels within exome-capture data (Fig. 1). By com-
bining the power of mapping and assembly, Scalpel carefully 
searches the de Bruijn graph for sequence paths (contigs) that 
span each exon. The algorithm includes an on-the-fly repeat 
composition analysis of each exon coupled with a self-tuning 
k-mer strategy.
Using simulated reads, we confirmed previous findings that nine 
standard algorithms have reduc d power to detect large (q30 bp) 
indels14,15: Scalpel, SOAPindel14, GATK-HaplotypeCaller, 
GATK-UnifiedGenotyper, SAMtools17, FreeBayes18, Platypus 
(http://www.well.ox.ac.uk/platypus), lobSTR19 and RepeatSeq20 
(Supplementary Notes 1 and 2, Supplementary Figs. 1 and 2 
and Supplementary Tables 1–5). We also performed a large-scale 
validation experiment involving ~1,000 indels from one single 
exome. The in ividual has a s vere c se of Tourette syndrome 
and obsessive-compulsive disorder (sample ID: K8101-49685); 
the exome was sequenced to q20× coverage over 80% of the 
exome target using the Agilent 44-Mb SureSelect capture proto-
col and Illumina HiSeq2000 paired-end reads, averaging 90 bp 
in length after trim ing. Indels were called using the three pipe-
lines that had performed best with our simulated reads: Scalpel 
v.0.1.1 beta, SOAPindel v.2.0.1 and GATK HaplotypeCaller v.2.4.3 
Accurate de novo and 
tr nsmitted ind l detection 
in exome-capture data 
using microassembly
Giuseppe Narzisi1,2, Jason A O’Rawe3,4, Ivan Iossifov1, 
Han Fang3,4, Yoon-ha Lee1, Zihua W g1,  
Yiyang Wu3,4, Ghol on J Lyon3,4, Michael Wigler1 & 
Michae  C Schatz1
We present an open-source algorithm, Scalpel (http://scalpel.
sourceforge.net/), which combines mapping and assembly for 
sensitive and specific discovery of insertions and deletions 
(indels) in exome-capture data. A detailed repeat analysis 
coupled with a self-tuning k-mer strategy allows Scalpel 
to outperform other state-of-the-art approaches for indel 
discovery, particularly in regions containing near-perfect 
repeats. We analyzed 593 families from the Simons Simplex 
Collection and demonstrated Scalpel’s power to detect long 
(q30 bp) transmitted events and enrichment for de novo likely 
gene-disrupting indels in autistic children.
Although the analysis of single-nucleotide variations (SNVs) has 
become a standard technique to study human genetics1, indels in 
DNA sequences cannot be detected as reliably2,3. Indels are the second 
most common source of variation in human genomes and the most 
common structu al variant4. Within microsatellites (simple sequence 
repeats, SSRs, of 1- to 6-bp motifs), i dels alter the length of the peat 
motif and have been linked to more than 40 neurological diseases5. 
Indels also are an important genetic component in autism: de novo 
indels that are likely to disrupt the encoded protein are nearly twice as 
abundant in affected children than in their unaffected siblings6.
Detecting indels is challenging for several reasons: (i) reads 
overlapping the indel sequence are more difficult to map7 and 
may be aligned with multiple mismatches rather than with a gap; 
(ii) irregularity in capture efficiency and nonuniform read distri
bution increase the number of false positives; (iii) increased error 
rates make indel detection very difficult within microsatellites; 
and, as shown in this study, (iv) localized near-identical repetitive 
sequences can create high rates of false positives. For these rea-
sons, the size of indels d tectabl  by available software tools has 
been relatively small, rarely more than a few dozen base pairs8.
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Two major paradigms are currently used for detecting indels. 
The first and most common approach is to map all of the input 
reads to the reference genome using a read mapper (such as 
Burrows-Wheeler Alignment tool (BWA), Bowtie or Novoalign), 
although the available algorithms are not as effective for mapping 
across indels of more than a few base pairs. Advanced approaches 
use paired-end information to perform local realignments to 
detect longer mutations (tools include GATK UnifiedGenotyper1 
and Dindel9), although, in practice, their sensitivity is greatly 
reduced for longer (q30 bp) variants. Split-read methods (such 
as Pindel10 and Splitread11) can theoretically find deletions of any 
size, but they have limited power to detect insertions owing to the 
short read length of current sequencing technologies. The second 
paradigm consists of performing de novo whole-genome assembly 
of the reads and detecting variations between the assembled con-
tigs and the reference genome12,13. Although it has the potential 
to detect larger mutations, in practice this paradigm is less sensi-
tive because detecting indels requires a fine-grained and localized 
analysis to correctly report homozygous and heterozygous muta-
tions. Recently, three approaches have been developed that use 
de novo assembly for variation discovery: GATK HaplotypeCaller, 
SOAPindel14 and Cortex15. Another recent approach, TIGRA16, 
also uses localized assembly, but it has been tailored for break-
point detection without reporting the indel sequence.
We present a DNA sequence microassembly pipeline, Scalpel, 
for detecting indels within exome-capture data (Fig. 1). By com-
bining the power of mapping and assembly, Scalpel carefully 
searches the de Bruijn graph for sequence paths (contigs) that 
span each exon. The algorithm includes an on-the-fly repeat 
composition analysis of each exon coupled with a self-tuning 
k-mer strategy.
Using simulated reads, we confirmed previous findings that nine 
standard algorithms have reduced power to detect large (q30 bp) 
indels14,15: Scalpel, SOAPindel14, GATK-HaplotypeCaller, 
GATK-UnifiedGenotyper, SAMtools17, FreeBayes18, Platypus 
(http://www.well.ox.ac.uk/platypus), lobSTR19 and RepeatSeq20 
(Supplementary Notes 1 and 2, Supplementary Figs. 1 and 2 
and Supplementary Tables 1–5). We also performed a large-scale 
validation experiment involving ~1,000 indels from one single 
exome. The individual has a severe case of Tourette syndrome 
and obsessive-compulsive disorder (sample ID: K8101-49685); 
the xome was sequenced to q20× cov rage over 80% of the 
exome target using the Agilent 44-Mb SureSelect capture proto-
col and Illumina HiSeq2000 paired-end reads, averaging 90 bp 
in length after trimming. Indels were called using the three pipe-
lines that had performed best with our simulated reads: Scalpel 
v.0.1.1 beta, SOAPindel v.2.0.1 and GATK HaplotypeCaller v.2.4.3 
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We present an open-source algorithm, Scalpel (http://scalpel.
sourceforge.net/), which combines mapping and assembly for 
sensitive and specific discovery of insertions and deletions 
(indels) in exome-capture data. A detailed repeat analysis 
coupled with a self-tuning k-mer strategy allows Scalpel 
to outperform other state-of-the-art approaches for indel 
discovery, particularly in regions containing near-perfect 
repeats. We analyzed 593 families from the Simons Simplex 
Collection and demonstrated Scalpel’s power to detect long 
(q30 bp) transmitted events and enrichment for de novo likely 
gene-disrupting indels in autistic children.
Although the analysis of single-nucleotide variations (SNVs) has 
become a standard technique to study human genetics1, indels in 
DNA sequences cannot be detected as reliably2,3. Indels are the second 
most common source of variation in human genomes and the most 
common structural variant4. Within microsatellites (simple sequence 
repeats, SSRs, of 1- to 6-bp motifs), indels alter the length of the repeat 
motif and have been linked to more than 40 neurological diseases5. 
Indels also are an important genetic component in autism: de novo 
indels that are likely to disrupt the encoded protein are nearly twice as 
abundant in affected children than in their unaffected siblings6.
Detecting indels is challenging for several reasons: (i) reads 
overlapping the indel sequence are more difficult to map7 and 
may be aligned with multiple mismatches rather than with a gap; 
(ii) irregularity in capture efficiency and nonuniform read distri-
bution increase the number of false positives; (iii) incr ased error 
rates make indel detection very difficult within microsatellites; 
and, as shown in this study, (iv) localized near-identical repetitive 
sequences can create high rates of false positives. For these rea-
sons, the size of indels detectable by available software tools has 
been relatively small, rarely more than a few dozen base pairs8.
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Integrating precision medicine in the
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ABSTRACT
Background. In recent years, there has been an explosion in the number of technical
and medical diagnostic platforms being developed. This has greatly improved our
ability to more accurately, and more comprehensively, explore and characterize
human biological systems on the individual level. Large quantities of biomedical
data are now being generated and archived in many separate research and clinical
activities, but there exists a paucity of studies that integrate the areas of clinical
neuropsychiatry, personal genomics and brain-machine interfaces.
Methods. A single person with severe mental illness was implanted with the
Medtronic Reclaim® Deep Brain Stimulation (DBS) Therapy device for Obsessive
Compulsive Disorder (OCD), targeting his nucleus accumbens/anterior limb of the
internal capsule. Programming of the device and psychiatric assessments occurred
in an outpatient setting for over two years. His genome was sequenced and vari-
ants were detected in the Illumina Whole Genome Sequencing Clinical Laboratory
Improvement Amendments (CLIA)-certified laboratory.
Results. We report here the detailed phenotypic characterization, clinical-grade
whole genome sequencing (WGS), and two-year outcome of a man with severe
OCD treated with DBS. Since implantation, this man has reported steady improve-
ment, highlighted by a steady decline in his Yale-Brown Obsessive Compulsive Scale
(YBOCS) score from⇠38 to a score of⇠25. A rechargeable Activa RC neurostimula-
tor battery has been of major benefit in terms of facilitating a degree of stability and
control over the stimulation. His psychiatric symptoms reliably worsen within hours
of the battery becoming depleted, thus providing confirmatory evidence for the
eYcacy of DBS for OCD in this person.WGS revealed that he is a heterozygote for the
p.Val66Met variant in BDNF, encoding a member of the nerve growth factor family,
and which has been found to predispose carriers to various psychiatric illnesses.
He carries the p.Glu429Ala allele in methylenetetrahydrofolate reductase (MTHFR)
and the p.Asp7Asn allele in ChAT, encoding choline O-acetyltransferase, with both
alleles having been shown to confer an elevated susceptibility to psychoses. We have
found thousands of other variants in his genome, including pharmacogenetic and
How to cite this article O’Rawe et al. (2013), Integrating precision medicine in the study and clinical treatment of a severely mentally ill
person. PeerJ 1:e177; DOI 10.7717/peerj.177
Figure 1 Sagittal and transverse computed tomography (CT) images of the brain and skull ofMA.We
show here sagittal and transverse sections taken from CT scans. Imaging was performed before (A) and
after (B) MA received deep brain stimulation surgery for his treatment refractory OCD. Two deep brain
stimulator probes can be seen to be in place from a bifrontal approach (B), with tips of the probes located
in the region of the hypothalamus. Leads traverse through the left scalp soft tissues. Streak artifact from
the leads somewhat obscures visualization of the adjacent bifrontal and left parietal parenchyma. We did
not observe any intracranial hemorrhage, mass eVect or midline shift or extra-axial fluid collection. Brain
parenchyma was normal in volume and contour.
DBS implant has contributed to any of these issues. Attempts to add fluoxetine at 80 mg
by mouth daily for two months to augment any eYcacy from the DBS and ERP were
unsuccessful, mainly due to no discernible benefit and prominent sexual side eVects. MA
still receives an injection of 37.5 mg risperidone every two weeks for his past history of
O’Rawe et al. (2013), PeerJ, DOI 10.7717/peerj.177 8/26
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Textbook	  chapter	  soon	  to	  be	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  in:	  
Involvement	  with	  Industry	  
	  
Advisory	  Boards	  
Other	  non-­‐paid	  consulKng:	  
Discovering	  idiopathic	  orphan	  
diseases:	  Ogden	  Syndrome	  and	  the	  Nt-­‐
acetylaKon	  of	  proteins.	  
Ogden	  Syndrome	  
We	  found	  the	  SAME	  mutaKon	  in	  two	  unrelated	  families,	  with	  a	  very	  similar	  
phenotype	  in	  both	  families,	  helping	  prove	  that	  this	  genotype	  contributes	  to	  the	  
phenotype	  observed.	  
These	  are	  the	  Major	  Features	  of	  the	  Syndrome.	  
Textbook	  Chapter	  on	  Ogden	  Syndrome	  in	  pending	  3rd	  Edi)on	  

Mutation 
WT 
C C C 
Pro37 
Proband  
Unaffected 
Brother 
C T T G G	  T C T C 
Ser37 
C 
T 
This is the mutation we found… one nucleotide change 
out of 6 billion nucleotides in a diploid genome. 
 
The mutation is a missense resulting in 
Serine to Proline change in Naa10p 
 
 - Ser 37 is conserved from yeast to human 
 - Ser37Pro is predicted to affect functionality 
  (SIFT and other prediction programs) 
    - Structural modelling of hNaa10p wt (cyan) and 
  S37P (pink)  
 
 
 
 
 
 
 
The	  muta)on	  disrupts	  the	  N-­‐terminal	  
acetyla)on	  machinery	  (NatA)	  in	  
human	  cells.	  	  
Slide	  courtesy	  of	  Thomas	  Arnesen	  
funcKon	  of	  Nα-­‐terminal	  acetylaKon	  	  
general	  
•  most	  abundant	  protein	  modiﬁcaKon	  in	  eukaryotes	  
•  NatA	  is	  the	  major	  NAT	  
	  
NAT	  func)on	  
•  protein	  funcKon	  (hemoglobin,	  acKn/tropomyosin…)	  
•  protein	  stability	  
•  proteasomal	  degradaKon	  via	  ubiquiKn	  ligase	  Doa10	  
•  avidity	  enhancer	  
•  protein	  targeKng	  to	  ER	  
Nα-­‐terminal	  acetyltransferases	  
human	  NATs	  
•  NatA-­‐NatF	  	  
•  associated	  with	  ribosome	  
•  act	  co-­‐translaKonally	  
•  disKnct	  substrate	  speciﬁcity	  
C 
O 
CH 
R 
NH3+ -OOC 
Ac-CoA CoA 
C 
O 
CH3 Nα-acetyl transferase 
C 
O 
CH 
R 
NH 
-OOC 


NAT	  ac)vity	  of	  recombinant	  hNaa10p	  
WT	  or	  p.Ser37Pro	  towards	  synthe)c	  
N-­‐terminal	  pep)des	  	  
increased NAA10’s ranking to first overall in just one
family. Furthermore, after combining variants from the
proband in family 1 with the obligate carrier mother in
family 2, VAAST identified NAA10 as the only statistically
significant candidate.
Although we have noted that the affected infants have
an aged appearance, we have not established any direct
link with progeria or other progeroid syndromes. The
autopsies did not reveal any premature arteriosclerosis or
degeneration of vascular smooth muscle cells, as is seen
in Hutchinson-Gilford progeria syndrome (MIM
176670).43,44 Cell lines now being derived from family 1
and possibly future animal models will provide important
insights about the pathophysiology underlying this previ-
ously unrecognized syndrome.
Supplemental Data
Supplemental Data include six figures and two tables and can be
found with this article online at http://www.cell.com/AJHG/.
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Figure 4. NAT Activity of Recombinant hNaa10p WT
or p.Ser37Pro toward Synthetic N-Terminal Peptides
(A and B) Purified MBP-hNaa10p WT or p.Ser37Pro were mixed
with the indicated oligopeptide substrates (200 mM for SESSS and
250 mM for DDDIA) and saturated levels of acetyl-CoA (400 mM).
Aliquots were collected at indicated time points and the acetyla-
tion reactions were quantified with reverse phase HPLC peptide
separation. Error bars indicate the standard deviation based on
three independent experiments. The five first amino acids in the
peptides are indicated, for further details see Subjects and
Methods. Time-dependent acetylation reactions were performed
to determine initial velocity conditions when comparing the WT
and Ser37Pro NAT activities toward different oligopeptides.
(C) Purified MBP-hNaa10p WTor p.Ser37Pro were mixed with the
indicated oligopeptide substrates (200 mM for SESSS and AVFAD
and 250 mM for DDDIA and EEEIA) and saturated levels of
acetyl-CoA (400 mM) and incubated for 15 min (DDDIA and
EEEIA) or 20 min (SESSS and AVFAD) at 37!C in acetylation buffer.
The acetylation activity was determined as above. Error bars
indicate the standard deviation based on three independent exper-
iments. Black bars indicate the acetylation capacity of the
MBP-hNaa10p WT, whereas white bars indicate the acetylation
capacity of the MBP-hNaa10p mutant p.Ser37Pro. The five first
amino acids in the peptides are indicated.
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Big	  QuesKons	  though:	  
 
Simulated	  structure	  of	  S37P	  mutant	  	  
?	  
What	  is	  the	  molecular	  basis	  of	  Ogden	  syndrome?	  
•  Naa10/Naa15	  complex	  
•  Naa10	  localisaKon	  
•  Naa10	  funcKon	  
what	  can	  we	  learn	  from	  Ogden	  syndrome?	  
•  characterizing	  diﬀerent	  model	  systems	  (ﬁbroblasts,	  iPS	  cells,	  yeast,	  mouse)	  
X-­‐chromosome	  skewing	  
skewing analysis on B-cells 
•  from wt and S37P carriers females 
	  Manuscript	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α-lamin α-tubulin 
DAPI merge 
α-lamin α-tubulin 
DAPI merge 
Lamin	  and	  tubulin	  staining	  in	  primary	  ﬁbroblasts	  
•  staining	  for	  lamin	  and	  tubulin	  
•  pictures	  were	  taken	  on	  Applied	  Precision	  DeltaVision	  (wide-­‐ﬁeld	  ﬂuorescence	  
microscope	  with	  deconvoluKon)	  
control boy (BJ) Ogden boy (MC) 
M-­‐1	  
Unassembled Samples: Traces for 1 sample
November 22, 2014 10:26:50 PM EST
Page 1 of 1
yiwu-M3-F2-form+
A T G A A A T A C T A C T T C T A C C
530
A T G G C C T T C C
540
C T G G C C C C A G
550
Unassembled Samples: Traces for 1 sample
November 22, 2014 10:30:46 PM EST
Page 1 of 1
yiwu-M4-F2-form+
A C T T C T A C C A T G
530
G C C T T C C C T G
540
G C C C C A G G T G
550
G G C A G C T
M-­‐2	  
M-­‐3	  
Ogden	  Genomic	  Locus	  
Pro	  	  
Unassembled Samples: Traces for 1 sample
November 22, 2014 10:34:13 PM EST
Page 1 of 1
yiwu-M5-F2-form+
A C T T C T A C C A T G
530
G C C T T C C C T G
540
G C C C C A G G T G
550
G G C A G C T
H-­‐1	  
Unassembled Samples: Traces for 1 sample
November 22, 2014 9:42:16 PM EST
Page 1 of 1
<< yiwu-H1-R2-form+
A A T A C T A C T T C T A C C A T G G
560
C C T T T C C T G G
570
C C C C A G G T G G
580
Unassembled Samples: Traces for 1 sample
November 22, 2014 9:47:35 PM EST
Page 1 of 1
yiwu-H2-F2+
G A A A T A C T A C T
520
T C T A C C A T G G
530
C C T T T C C T G G
540
C C C C A G G T G G
550
G C A G C T T C T
Unassembled Samples: Traces for 1 sample
November 22, 2014 9:51:20 PM ES
Page 1 of 1
<< yiwu-H3-R2+
A T A C T A C T T C T A C C
860
A T G G C C T T T C
870
C T G G C C C C A G
880
G T G G G C A GH-­‐2	  
H-­‐3	  
Phase	  
WT	  Genomic	  Locus	  	  
Ser	  	  
Sanger	  sequencing	  results	  of	  genomic	  DNA	  from	  WT	  HDFn-­‐iPSCs	  (lep)	  and	  Ogden	  
MC-­‐iPSCs	  (right).	  The	  c.109T>C	  mutaKon	  in	  exon	  2	  of	  Naa10	  is	  indicated	  by	  the	  red	  
asterisk,	  and	  the	  codon	  change	  from	  Serine	  to	  Proline	  is	  illustrated	  respecKvely.	  
Naa10	  S37P	  MutaKon	  ValidaKon	  in	  iPSCs	  
CharacterizaKon	  of	  iPSCs	  
Immunoﬂuorescence	  analysis	  of	  the	  indicated	  pluripotent	  markers	  in	  HDFn-­‐iPSCs	  (lep)	  and	  
Ogden-­‐iPSCs	  (right).	  Nuclei	  were	  visualized	  with	  DAPI	  stain	  (blue).	  Scale	  bar,	  150 μm.	  
Sox2	   Oct4	   Nanog	  
Ogden-iPSCs	  HDFn-iPSCs	  
TRA-­‐
1-­‐60	  
DAPI	  
Merge	  
S/O/N	  
Sox2	   Oct4	   Nanog	  
Cardiac	  Lineage	  DiﬀerenKaKon	  	  
WT	  	  iCM	  on	  Day	  41	   Ogden	  	  iCM	  on	  Day	  38	  
IniKal	  cardiac	  diﬀerenKaKon	  assay	  showed	  wave-­‐like	  beaKng	  
sheets	  of	  cells	  derived	  from	  WT	  and	  Ogden	  iPSCs	  when	  plated	  on	  
matrigel	  on	  Day	  41	  and	  Day	  38,	  respecKvely.	  Scale	  bar,	  250	  μm.	  
=	  paKent	  samples	  prepared	  for	  N-­‐terminal	  COFRADIC	  analyses	  (but	  sKll	  
to	  be	  analyzed)	  (#8	  and	  #9)	  
=	  FFPE	  DNA	  (for	  paKent	  III.7.)	  or	  DNA	  from	  blood	  available	  (and	  for	  
some	  of	  them:	  EBV	  transformed	  cell	  lines	  available	  +	  skin	  ﬁbroblast	  of	  
paKent	  III.6.)	  
=	  male	  
=	  female	  
=	  sKllborn	  SB	  
=	  proband	  
I
II	  
III	  
SB	  
1.	   2.	  
4.	  1.	   2.	   3.	   5.	   6.	   7.	   8.	  
1.	   2.	   3.	   4.	   5.	   7.	  6.	  
+|	   +/mut	  
mut	  |	  
mut	  |	   mut	  |	  
carrier	  WT	  
MUT	  
MUT	  MUT	  
MUT	  carrier	   carrier	  
+/mut	   +/mut	  
carrier	  
+/mut	   +/+	  
WT	  
+|	  
WT	  
+|	  
WT	  
+/+	  
WT	  
mut	  |	  
MUT	  
A.	  B.	  
+|	  
WT	  
=	  paKent	  samples	  analyzed	  by	  N-­‐terminal	  COFRADIC	  analyses	  (#1	  to	  #5)	  
III.4.	  proband	  hemizygous,	  mutant	  (89323)	  (#1a)	  (#1b)	  
II.2.	  mother	  of	  proband,	  carrier	  (89324)	  (#2)	  
II.A.	  married-­‐in	  father	  of	  proband,	  WT(89325)	  
III.2.	  brother	  of	  proband,	  WT(90526)	  (#3)	  
III.1.	  sister	  of	  proband,	  WT	  (90527)	  (#4)	  
I.2.	  grandmother	  of	  proband,	  carrier	  (90528)	  
I.1.	  married-­‐in	  grandfather	  of	  proband,	  WT(90529)	  (#5)	  
II.7.	  aunt	  of	  proband,	  WT	  (90530)	  (#6)	  
II.3.	  aunt	  of	  proband,	  carrier	  (90531)	  
II.B.	  married-­‐in	  uncle	  of	  proband,	  WT(90532)	  (#8)	  
II.8.	  uncle	  of	  proband,	  WT(90688)	  (#9)	  
II.5.	  aunt	  of	  proband,	  carrier	  with	  deceased	  boy	  (90797)	  (#7)	  
Proteomics	  Analysis	  of	  EBV-­‐transformed	  cell	  lines	  
and	  ﬁbroblasts	  from	  family	  members	  
Proteomics	  Strategy	  
With	  Thomas	  Arnesen,	  
Petra	  van	  Damme	  
And	  Kris	  Gevaert	  

6 
 
 
Figure S6. Reduced Nt-acetylation for specific Nat-type N-termini in proteomes of B-cells derived from 
males with Ogden syndrome. Representative scatter plots displaying the correlation of the degrees of Nt-
acetylation of all N-termini identified in the N-terminal proteomes of Naa10-WT, Naa10-S37P (Ogden male) 
and carriers of the S37P mutation. III-4; Ogden male (S37P), III-2; brother of Ogden male III-4, III-6; Ogden 
male (S37P), II-2; mother  of Ogden male III-4, III-1; sister  of Ogden male III-4, I-1; grandfather, II-7; aunt, II-
5; aunt (carrier of S37P), II-C; uncle, married into Ogden family, II-8; uncle, II-A; uncle, married into Ogden 
family, I-2; grandmother (carrier of S37P) and II-3; mother (carrier of S37P) of Ogden male III-6. 
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Table	  1:	  	  Overview	  of	  N-­‐termini	  less	  acetylated	  in	  Naa10-­‐S37P	  B-­‐cells,	  ﬁbroblasts	  and	  siNatA	  
HeLa	  cells.	  
	  	  
IP	  and	  mass	  spec	  of	  NAA10	  
5 x 106 HEK293 cells were seeded in 10 cm dish and 
transfected after 24 h with pcDNA3.1 V5/His hNaa10 
wt, pcDNA3.1 V5/His hNaa10 S37P or corresponding 
empty vector. Cells were lysed after 48 h . 
 
For IP, 40 mg total protein were incubated with 400 µl 
anti-V5-coupled magnetic beads (Invitrogen) for 2 h at 
4°C under constant agitation.  
 
Proteins were digested with trypsin off the beads 
and labelled with distinct isobaric iTRAQ reagents. 
The samples were combined and subjected to 
standard 2D MudPIT LCMS and analyzed using a 
Thermo Velos Orbitrap mass spectrometer.  
 
The relative enrichment in the samples were 
calculated as a ratio of the intensities between the 
samples and the empty-vector control. The whole 
experiment was done twice. 
slides	  IP	  &	  mass	  spec	  
wt S37P
1 RPLP1* 60S acidic ribosomal protein P1 30.3 23.7
2 RPS25* 40S ribosomal protein S25 29.4 18.1
3 NACA Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Fragment) 27.5 11.0
4 HYPK Huntingtin-interacting protein K 27.0 4.3
5 RPL38* 60S ribosomal protein L38 26.8 18.3
6 RPL8* 60S ribosomal protein L8 24.7 14.4
7 RPS13* 40S ribosomal protein S13 24.1 13.5
8 RPS28* 40S ribosomal protein S28 23.8 14.6
9 FAU* 40S ribosomal protein S30 23.7 15.9
10 RPL27A* 60S ribosomal protein L27a 21.9 11.9
11 RPL6* 60S ribosomal protein L6 21.8 13.7
12 CAPRIN1 Caprin-1 21.7 12.4
13 GPATCH4 G patch domain-containing protein 4 21.4 15.3
14 NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subunit 21.2 5.2
15 RPS18* 40S ribosomal protein S18 20.9 12.0
16 RPS14* 40S ribosomal protein S14 20.7 11.6
17 RPS19* 40S ribosomal protein S19 20.3 12.8
18 RPL13* 60S ribosomal protein L13 19.9 11.5
19 NDNL2 Melanoma-associated antigen G1 19.6 4.7
20 RPS16* 40S ribosomal protein S16 19.5 13.6
*ribosomal protein
DescriptionName
Enrichment
Nr.
Top 20 hits
0
5
10
15
20
25
30
re
l. 
en
ric
hm
en
t
selected interaction partners
wt S37P
wt S37P
re
l. 
en
ric
hm
en
t
wt S37P
0
10
20
30
40
50 selected interaction partners
*
*
* Naa38 was only found in one set
* Naa38 was only found in one set
0
10
20
30
40
50
BT
F3
NA
A1
0
KR
T9
NA
A1
5
NA
A1
6
NA
A5
0
NA
A3
8
HY
PK
NA
CA
BT
F3
4L
NAC	  
+ empty vector 
+ hNatA wt 
+ hNatA S37P 
+ empty vector 
w
t 
Δ
N
at
A 
0.00	  
0.20	  
0.40	  
0.60	  
0.80	  
1.00	  
1.20	  
1.40	  
1.60	  
30°C	   37°C	   30°C	   37°C	   30°C	   37°C	   30°C	   37°C	  
empty	  vector	   empty	  vector	   hNatA	  wt	   hNatA	  S37P	  
re
l.	  
gr
ow
th
	  
wt ΔNatA 
      30 °C                   39 °C	  
B
'yNatAwt
hNatA wt
hNatA S37P 
-
-
-
-
+
-
-
+
kDa
yNaa1035
yNaa15100
hNaa1035
100 hNaa15
yGAPDH
35
0.0	  
0.2	  
0.4	  
0.6	  
0.8	  
1.0	  
1.2	  
wt	   k/o	   hNatA	   hNatA	  
S37P	  
wt	   k/o	   hNatA	   hNatA	  
S37P	  
30°C	   37°C	  
Same data, just presented differently. 
yeast growth 
YPDA media (Clonetech, #630464) 
Yeast minimal SD base (Clonetech, #630411) 
supplemented with drop out mix –Ura 
(Clonetech, #630416) 
 
A 5 ml overnight culture was grown in SD-URA 
at 30°C. Cells were diluted to an OD600 of 0.1 
and either spotted in 1:5 serial dilutions on 
plates for 48 h (upper panel) or grown in 2 ml 
cultures at 30°C or 39°C under constant 
agitation for 24 h (lower panel). Optical 
density was plotted  
n=11 
Endogenous, single-copy genes in 
yeast. 
 
Optical density as a measure of 
growth was normalized to the W303 
wt strain for every independent 
experiment and plotted (X). The 
median of all experiments is shown 
as a short line 
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Conclusions	  
•  Expanding	  Utah	  Genome	  Project	  signiﬁcantly.	  
•  Making	  good	  progress	  on	  many	  new	  rare,	  
orphan	  diseases.	  
•  Working	  toward	  highly	  accurate	  whole	  genome	  
sequencing.	  
•  ElaboraKng	  the	  mechanisKc	  basis	  of	  Ogden	  
Syndrome	  in	  molecular	  detail.	  
The	  End	  
